Drug Database
Back to search

Netherlands· NL-ef974f266f80

Cabazitaxel Vivanta 60 mg concentraat en oplosmiddel voor oplossing voor infusie

A cabazitaxel product containing cabazitaxel, registered in Netherlands by Vivanta Generics s.r.o.. The same ATC class is registered in 15 of our 19 countries.

ATC L01CD04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCabazitaxel Vivanta 60 mg concentraat…ATCL01CD04REGISTER NO.NL-ef974f266f80PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cabazitaxelAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cabazitaxel is registered in 15 of 19 countries.

Countries holding a registration under ATC L01CD04 (cabazitaxel), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search cabazitaxel products by name

Cabazitaxel · ATC L01CD04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cabazitaxel costs, country by country.

Normalised to the WHO defined daily dose (2.14 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cabazitaxel · price per daily dose (2.14 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$115.73
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CABAZITAXEL
Manufacturer
Vivanta Generics s.r.o.
Country
Netherlands (NL)
ATC code
L01CD04
ATC class
Cabazitaxel
Defined daily dose
2.14 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    124779

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

300 interactions on record for cabazitaxel.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cabazitaxel against other medicinesHow interaction checks work

Cabazitaxel · interactions on record

300 records

  • 29 severe
  • 269 moderate
  • 2 minor

Most severe, free to view

  • CladribineL01BB04severe
  • ClotrimazoleA01AB18moderate
  • AprepitantA04AD12moderate
  • MiconazoleA07AC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cabazitaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cabazitaxel products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Cabazitaxel Ever Pharma 10 Mg/Ml Konzentrat Zur Herstellung Einer Infusionslösung, Cabazitaxel Fresenius Kabi
  • Belgium · Cabazitaxel Eg (Eurogenerics), Cabazitaxel Eugia
  • Bulgaria · Елебер, Кабазитаксел Ever Pharma 10 Mg/Ml Концентрат За Инфузионен Разтвор
  • Czechia · Cabazitaxel Agmed, Cabazitaxel Ever Pharma
  • Germany · Cabazitaxel Aqvida, Cabazitaxel Axiromed
  • Denmark · Cabazitaxel "medical Valley", Cabazitaxel "sandoz"
  • Estonia · Cabazitaxel Fresenius Kabi, Cabazitaxel Sandoz
  • Spain · Cabazitaxel Aurovit, Cabazitaxel Dr. Reddys
  • Finland · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • France · Cabazitaxel Eg Labo, Cabazitaxel Ever Pharma
  • United Kingdom (Northern Ireland) · Cabazitaxel Dr. Reddy's Laboratories (Uk), Cabazitaxel Fresenius Kabi
  • Greece · Cabazitaxel /Fresenius Kabi, Cabazitaxel Ariti
  • Croatia · Eleber, Kabazitaksel Ever Pharma 10 Mg/Ml Koncentrat Za Otopinu Za Infuziju
  • Hungary · Cabazitaxel, Cabazitaxel Ever Pharma
  • Ireland · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Iceland · Cabazitaxel Accord, Cabazitaxel Stada
  • Italy · Cabazitaxel Dr. Reddy’s, Cabazitaxel Ever Pharma
  • Liechtenstein · Cabazitaxel Accord, Jevtana
  • Lithuania · Cabazitaxel Fresenius Kabi, Cabazitaxel Sandoz
  • Luxembourg · Cabazitaxel Eg, Cabazitaxel Eugia
  • Latvia · Cabazitaxel Fresenius Kabi, Cabazitaxel Stada
  • Malta · Cabazitaxel Fresenius Kabi
  • Norway · Cabazitaxel Accord, Cabazitaxel Ever Pharma
  • Poland · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Portugal · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Romania · Cabazitaxel Aqvida, Cabazitaxel Ever Pharma
  • Sweden · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi
  • Slovenia · Cabazitaxel Ever Pharma, Eleber
  • Slovakia · Cabazitaxel Ever Pharma, Cabazitaxel Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc38c448-ba6f-4dbf-a36f-3eb43519ad42
GET /v1/drugs/dc38c448-ba6f-4dbf-a36f-3eb43519ad42?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat en oplosmiddel voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124779_smpc.pdf",
  "strength": null,
  "atc_label": "Cabazitaxel",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124779",
  "excipients": [
    "ETHANOL",
    "ETHANOL 96 %",
    "POLYSORBAAT 80 (E 433)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "CABAZITAXEL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124779.pdf",
  "authorised_at": "2021/12/15",
  "procedure_number": "NL/H/4861/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "124779",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about cabazitaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console